Antithrombin prevents endotoxin-induced pulmonary vascular injury by inhibiting leukocyte activation

Blood Coagulation and Fibrinolysis

Volumn 9, Issue SUPPL.. 2, 1998, Pages

  Okajima, Kenji ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Acute respiratory distress syndrome; Antithrombin; Disseminated intravascular coagulation; Endothelial cell injury activated leukocytes; Glycosaminoglycans; Prostacyclin; Sepsis

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANTITHROMBIN; ENDOTOXIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; GLYCOSAMINOGLYCAN; INDOMETACIN; MYELOPEROXIDASE; PROSTACYCLIN;

ANIMAL CELL; ANIMAL TISSUE; BLOOD VESSEL INJURY; CELL INTERACTION; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; LEUKOCYTE ACTIVATION; LUNG INJURY; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REVIEW; SEPSIS; SURVIVAL RATE;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ANTITHROMBIN III; ENDOTOXINS; EPOPROSTENOL; HEPARIN; HUMANS; LUNG; NEUTROPHIL ACTIVATION; RATS; VASCULAR DISEASES;

EID: 0031803027     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Emerson TE Jr, Fournel MA, Redens TB, Taylor FB Jr. Efficacy of antithrombin III supplementation in animal model of fulminant Escherichia coli endotoxemia or bacteremia. Am J Med 1989;87 (suppl 3B):L27S-33S.
2. Vinazzer H. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation. Semin Thromb Hemost 1989; 15: 347-352.
3. Triantaphyllopoulos DC. Effect of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin. Thromb Haemost 1984;51:232-235.
4. Taylor FB Jr, Emerson TW Jr, Jordan R, Chang AK, Blick KE. Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboon. Circ Shock 1988; 26: 227-235.
5. Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K. Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III. Am J Physiol 1996;270:L921-L930.
6. Uchiba M, Okajima K, Murakami K, Okabe H, Tukatsuki K. Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats. Thromb Res 1995;78:117-125.
7. Okajima K, Uchiba M. The anti-inflammatory properties of antithrombin III: new therapeutic implications.Semin Thromb Hemost 1998;24:27-32.
8. Uchiba M, Okajima K, Murakami K. Effects of various doses of antithrombin III on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats. Thromb Res 1998 (in press).
9. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 1996; 87: 642-647.
10. Yamauchi T, Umeda F, Inoguchi T, Nawata H. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun 1989; 163: 1404-1411.
11. Horie S, Ishii H, Kasama M. Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent not for thrombin-dependent prostacyclin production in human endothelial cells. Thromb Res 1990; 59: 895-904.
12. Maria Riva C, Morganroth ML, Ljungman AG, Schoeneich SO, Marks RM, Todd RF III, et al. Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers. Am J Respir Cell Mol Biol 1990; 3: 301-309.
13. 1α in rats. Thromb Res 1995; 80: 201-208.
14. Okajima K. New therapeutic implications of antithrombin III replacement in disseminated intravascular coagulation and multiple organ failure.Intensivmed 1996; 33: 5-11.